ARTICLE

FindCenter AddIcon

Study with Ravers Suggests Psychedelics Linked to Social Bonding and Prosocial Behaviours

By Olivia Miller — 2021

New research from Kent has identified prosocial behaviours and bonding amongst people who attend raves, which may help explain why rave culture has endured for the last thirty years.

Read on www.kent.ac.uk

FindCenter Post-Image

The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same.

After decades of demonization and criminalization, psychedelic drugs are on the cusp of entering mainstream psychiatry, with profound implications for a field that in recent decades has seen few pharmacological advancements for the treatment of mental disorders and addiction.

FindCenter AddIcon
FindCenter Post-Image

A Psychedelic Drug Passes Big Test for PTSD Treatment

In an important step toward medical approval, MDMA, the illegal drug popularly known as Ecstasy or Molly, was shown to bring relief to those suffering from severe post-traumatic stress disorder when paired with talk therapy.

FindCenter AddIcon
FindCenter Post-Image

Psychedelics and Race: A Profile of Dr. Monnica T. Williams

The exuberant “renaissance” of studies researching psychedelic-assisted psychotherapy in the past twenty years has not sufficiently included the enrollment of racially diverse participants, a problem that psychedelic science and clinical research shares with mainstream psychiatry

FindCenter AddIcon
FindCenter Post-Image

Psychedelics Could Trigger a ‘Paradigm Shift’ in Mental Health Care

A new review of studies finds that LSD, psilocybin, and MDMA hold potential for treating mental illness.

FindCenter AddIcon
FindCenter Post-Image

Mind Molding Psychedelic Drugs Could Treat Depression, and Other Mental Illnesses

It seems that psychedelics do more than simply alter perception. According to the latest research from my colleagues and me, they change the structures of neurons themselves.

FindCenter AddIcon
FindCenter Post-Image

How Ecstasy and Psilocybin Are Shaking Up Psychiatry

Regulators will soon grapple with how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder.

FindCenter AddIcon
FindCenter Post-Image

MDMA Lauded as ‘Breakthrough’ Therapy for PTSD Patients

The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.

FindCenter AddIcon

EXPLORE TOPIC

Psychedelic Research